The relationship between fatigue and light exposure during chemotherapy

Area of Science:

• Oncology
• Circadian Biology
• Psychoneuroimmunology

Background:

• Cancer-related fatigue is a prevalent and distressing symptom impacting patients during and after treatment.
• Fatigue significantly diminishes patients' quality of life and can lead to treatment discontinuation.
• Disrupted circadian rhythms and reduced light exposure are hypothesized contributors to cancer-related fatigue.

Purpose of the Study:

• To investigate the association between fatigue levels and light exposure in breast cancer patients.
• To explore potential links between circadian rhythm disruption and cancer-related fatigue.

Main Methods:

• Analysis of 63 women with newly diagnosed stage I-IIIA breast cancer undergoing chemotherapy.
• Data collection on fatigue and light exposure before and during chemotherapy cycles (1 and 4).
• Fatigue assessed using the Multidimensional Fatigue Symptom Inventory; light exposure measured via wrist actigraphy.

Main Results:

• Significant negative correlations (r=-0.28 to -0.45) found between fatigue and light exposure during chemotherapy cycles.
• Higher fatigue levels were consistently associated with lower light exposure.
• Changes in light exposure correlated with changes in fatigue within the initial weeks of chemotherapy cycles.

Conclusions:

• Decreased light exposure is significantly correlated with increased fatigue in breast cancer patients.
• While causality is not confirmed, light exposure may play a role in alleviating cancer-related fatigue.
• Results support the need for intervention studies on light therapy for managing breast cancer fatigue.